• share
• favorite_border

The Atlantic Health System lung cancer test uses low-dose computed tomography (LDCT) that only takes a few minutes to complete and may identify lung cancer at earlier, more curable stages. When compared to chest X-rays used in early detection, the LDCT screening reduces lung cancer deaths in high-risk individuals by 20 percent. The screening test is covered by Medicare and most commercial insurance. Approximately 2% of screenings show early findings of lung cancer.

• share
• favorite_border

November is national Pancreatic Cancer Awareness month. This year alone, more than 56,000 Americans will be diagnosed with pancreatic cancer. Pancreatic tumors are particularly aggressive and hard to treat "due to a mutational profile that makes it resistant to therapies that work better for other tumor types," explains Angela Alistar, MD, medical director of GI oncology at Morristown Medical Center. Dr. Alistar, an internationally known expert on pancreatic cancer, is now enrolling patients in five clinical trials aimed at pancreatic cancer.

• share
• favorite_border

Atlantic Health System is treating patients in a new Phase 2 clinical trial of CAR T-cell therapy at Morristown Medical Center. A select number of sites across the U.S. are involved in this study, which is done on an outpatient basis. The study is sponsored by Juno Therapeutics, Inc. The study’s principal investigator, Mohamad Cherry, MD, medical director of hematology for Atlantic Health System Cancer Care, is a nationally known expert at treating and researching blood-related cancers such as lymphoma, leukemia and myeloma. Dr. Cherry is triple board-certified in internal medicine, hematology and medical oncology

• share
• favorite_border

Atlantic Health System Cancer Care at Overlook Medical Center is now offering a highly advanced technology that will enhance the ability of physicians to diagnose, stage and treat prostate cancer. The UroNav Fusion Biopsy System fuses pre-biopsy magnetic resonance imaging (MRI) images of the prostate with ultrasound-guided 3-D images in real time, allowing for excellent imaging of the prostate and any abnormal changes (lesions) that may or may not be cancerous.

• share
• favorite_border

10 Things Women Should Know About Preeclampsia

• share
• favorite_border

The MIND study compares the safety and efficacy of a neuro-evacuation device to best medical management in evacuating intracerebral hemorrhage - a life-threatening kind of stroke which occurs when a diseased blood vessel within the brain bursts.

• share
• favorite_border

The National Cancer Institute (NCI) has designated Atlantic Health System as a National Community Oncology Research Program (NCORP) site of the Atlantic Health Cancer Consortium (AHCC). As New Jersey’s first and only NCORP, AHCC will help develop and implement NCI cancer prevention, screening, care delivery and treatment studies with leading health care systems across the state.

• share
• favorite_border

The first surgery in New Jersey using the ROSA Brain robot was performed by Ronald Benitez, MD, chief of endovascular neurosurgery, Overlook Medical Center. Conventional brain surgery for epilepsy requires a craniotomy. Using ROSA Brain, surgeons make tiny holes in the skull through which they insert electrodes to record brain activity and help pinpoint exactly which part of the brain is responsible for seizures. The robot can also assist in deep brain stimulation, trans-nasal and ventricular endoscopy, and brain biopsies.

• share
• favorite_border

Atlantic Melanoma Center is among the nation’s leading cancer programs participating in the clinical trials of a new type of personalized immunotherapy known as TIL (tumor infiltrating lymphocyte) therapy, in which the patient’s own immune system cells are removed from his/her tumor, treated with an immune booster and then infused back into the patient, along with a medication that stimulates the immune system. Iovance Biotherapeutics is developing TIL therapy for soild tumors and is currently conducting the pivotal study innovaTIL-01 in patients with metastatic melanoma. Atlantic Melanoma Center at Morristown Medical Center is the only site in New Jersey to treat patients with this unique experimental therapy.

• share
• favorite_border

Studies to be presented at the ASCO meeting are co-authored by research oncologists Eric Whitman, MD; Missak Haigentz, MD; and Angela Alistar, MD. Their ASCO studies include: two separate studies looking at TILS therapy and Keytruda for advanced melanoma; immunotherapy for metastatic head and neck cancer; treatment for recurrent Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma; and a combination of CPI-613 -- a new type of medication, pioneered by Dr. Alistar, known as an altered energy metabolism drug -- with 5-FU in treating metastatic colorectal cancer.

• share
• favorite_border

RAPID provides the most advanced brain imaging to stroke experts. The platform is noteworthy for its ability to shave time from the treatment decision-making process: Images are transmitted from patients’ CTA (computed tomography angiography) and CTP (computed tomography perfusion) to hospital systems and physicians’ smart phones within just minutes.

• share
• favorite_border

Morristown Medical Center Team Finds Listening to Teens May Help Them Better Control Type 1 Diabetes

• share
• favorite_border

Morristown Medical Center Pediatric Orthopedic Surgeon Finds Obtaining Vitamin D Levels in Children with Fractures Improves Compliance

• share
• favorite_border

Morristown Medical Center Nursing Research Team Finds Pet Therapy Visits Reduce Anxiety in Hospitalized Children

• share
• favorite_border

Dr. Gillam presented with Master of the ACC Award at ACC’s 68th Annual Scientific Session; was recognized in 2018 as Gifted Educator of the Year

• share
• favorite_border

Atlantic Health System’s Morristown Medical Center, ranked one of the top 20 cardiology programs in the country by U.S. News & World Report, will be prominently featured at the American College of Cardiology’s 68th Annual Scientific Session, one of the premier meetings in the world for cardiology. The meeting will take place March 16-18 in New Orleans.

• share
• favorite_border

The WavelinQ uses radio frequency (RF), to create the connection between a vein and artery, called a fistula, which is an important step in dialysis treatment for patients. This endo-AVF (arteriovenous fistula) procedure marks the first major advancement in fistula creation in the last 50 years.

• share
• favorite_border

Atlantic Health System’s Morristown Medical Center and Overlook Medical Center were the only hospitals in New Jersey to achieve America’s 50 Best Hospitals Award™ and America’s 100 Best Hospitals Award™ from Healthgrades, respectively.

• share
• favorite_border

Dr. Farber Leads Oncology Research Network Development and Dr. Scola Directs Atlantic Thrombosis Center

• share
• favorite_border

Researchers at Atlantic Sports Health found people using wearable fitness trackers mere more motivated when they had access to the information they provide, not just from wearing the device.

• share
• favorite_border

Atlantic Health System, an integrated health care delivery system, today announced a partnership with the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and Origin Commercial Ventures to create a new platform to deliver economically viable immunotherapies and other breakthrough cancer treatments to the region through expedited access and novel payment options.

• share
• favorite_border

Advances in technology are rapidly changing the way many gynecologic conditions and procedures are treated, and the traditional long hospital stays and complicated, invasive procedures requiring weeks of bedrest are being replaced with less complicated, minimally invasive procedures that simply get women back to their lives sooner.

• share
• favorite_border

Atlantic Health System is now enrolling patients in four pancreatic cancer clinical trials. Angela Alistar, MD, a nationally known expert on pancreatic cancer, is serving as national Principal Investigator (PI) on the first trial and as local PI on three other trials.

• share
• favorite_border

Following successful Phase 1 clinical trials, the Toca regimen – a new immunotherapy for patients with recurrent brain cancer – has advanced to a Phase 3 study, which is currently underway. The trial is being conducted at 68 sites across the United States, Canada, Israel and South Korea, including at Overlook Medical Center’s Gerald J. Glasser Brain Tumor Center, one of three clinical trial sites in New Jersey. In this surgical study, patients are randomized to either standard of care treatment or the Toca regimen. Enrollment is expected to complete in this trial by the end of 2018.

• share
• favorite_border

Atlantic Health System’s new Atlantic HPV Center is one of a small number of research centers in the nation to begin a study to determine whether an innovative combination of immuno-oncology treatments is safe, shows preliminary efficacy and provokes an anticancer immune system response in patients with recurrent or metastatic human papilloma virus (HPV) associated head and neck squamous cancer.

• share
• favorite_border

Atlantic health system cardiologist authors new review on value of non-invasive imaging techniques in valvular heart disease patients

• share
• favorite_border

The Gerald J. Glasser Brain Tumor Center of Overlook Medical Center’s Atlantic Neuroscience Institute and Carol G. Simon Cancer Center is one of four sites in the country to begin a Phase III clinical trial of the novel drug VAL-083 for patients whose glioblastoma multiforme or gliosarcoma has progressed during or after treatment with the standard of care chemo-radiation therapy. Other study locations are: Kaiser Permanente Los Angeles Medical Center; University of California, San Francisco; and Dent Neurosciences Research Center, Amherst, NY.

• share
• favorite_border

Mohamad Cherry, MD, leads a major session on new discoveries about the most common type of acute adult leukemia and helps present results of four major blood cancer studies at the American Society of Hematology (ASH) 59th Annual Meeting, December 9-12 in Atlanta, GA. The meeting is the world’s pre-eminent gathering of clinicians and researchers focused on blood diseases, who travel from nearly 100 countries to hear the latest research developments. An internationally known hematology/oncology researcher, Dr. Cherry recently joined Atlantic Hematology Oncology, part of Atlantic Health System’s Atlantic Medical Group at Morristown Medical Center’s Carol G. Simon Cancer Center, from the University of Oklahoma Health Sciences Center’s Stephenson Cancer Center.

• share
• favorite_border

Nationally renowned gastrointestinal (GI) cancer physician-scientist Angela Alistar, MD thinks it is critical that everyone learn how to recognize the warning signs of pancreatic cancer. Dr. Alistar is medical director of GI medical oncology at the Carol G. Simon Cancer Center of Morristown Medical Center, Atlantic Health System.